Objective. To evaluate the association between overweight/obesity and multidrug resistance in patients with and without a history of tuberculosis treatment. Materials and methods. Cross-sectional study of secondary data from a tuberculosis cohort, which included anthropometric and drug-sensitivity testing data at the baseline visit of patients with and without previous tuberculosis treatment. Results. We evaluated 3,734 new cases and 766 with a history of having received treatment for tuberculosis. Overweight/ obesity was not associated with multidrug resistance in patients with a history of tuberculosis treatment, with a prevalence ratio of 0.97 and a 95% confidence interval of 0.68-1.38. Conclusions. Overweight/ obesity is not associated with multidrug resistance in tuberculosis. Overweight/obesity is a dynamic pro-cess that may influence the relationship between the immune system and the metabolic system.
CITATION STYLE
Peinado, J., Lecca, L., Jiménez, J., Calderón, R., Yataco, R., Becerra, M., & Murray, M. (2023). ASSOCIATION BETWEEN OVERWEIGHT/OBESITY AND MULTIDRUG-RESISTANT TUBERCULOSIS. Revista Peruana de Medicina Experimental y Salud Publica, 40(1), 59–66. https://doi.org/10.17843/rpmesp.2023.401.12138
Mendeley helps you to discover research relevant for your work.